MEDIZEN HUMANCARE Inc. (XKON:236340)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,400.00
-100.00 (-4.00%)
At close: Jun 19, 2026
Market Cap5.53B +4.3%
Revenue (ttm)583.88M +512.1%
Net Income-1.69B
EPS-821.00
Shares Out 2.30M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume170
Open2,300.00
Previous Close2,500.00
Day's Range2,130.00 - 2,500.00
52-Week Range1,300.00 - 4,015.00
Beta0.46
Analystsn/a
Price Targetn/a
Earnings Daten/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile